Candice Shea, MD
Obstetrics & Gynecology · Southington, CTNPI 1548447170
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations.
Across 43 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$149
- Exeltis, USA Inc.$84
- Mayne Pharma Commercial LLC$74
- Astellas Pharma US Inc$72
- Coopersurgical, Inc.$51
- Sumitomo Pharma America, Inc.$45
- plus $336 from 15 others
What the payments were for
- Food & beverage$79698%
- Education$152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $149 |
| Exeltis, USA Inc. | 4 | $84 |
| Mayne Pharma Commercial LLC | 4 | $74 |
| Astellas Pharma US Inc | 3 | $72 |
| Coopersurgical, Inc. | 3 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Therapeuticsmd, Inc. | 2 | $37 |
| Millicent US Inc | 2 | $34 |
| Evofem Biosciences, Inc. | 2 | $31 |
| Merck | 2 | $28 |
| Avion Pharmaceuticals | 2 | $26 |
| Stryker | 1 | $24 |
| Urovant Sciences Inc | 1 | $21 |
| Smith+Nephew | 1 | $19 |
| Myovant Sciences Inc. | 1 | $19 |
| Pfizer | 1 | $19 |
| Bayer | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $17 |
| Minerva Surgical, Inc | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $14 |
How this compares
$811 in reported general payments places this provider in the 65th percentile of 605 obstetrics & gynecology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 14 | $1,020 |
| Clobetasol Propionate | 11 | $212 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Southington
- Mary MinkinNew Haven$285K
- Alessandro SantinNew Haven$98K
- Frederick RauHartford$89K
- Peter AuerbachGroton$41K
- Shieva GhofranyStamford$33K
- Mark LeondiresNorwalk$31K
- Alan FineHartford$30K
- Sean FlahertyHamden$28K
- Adam SteinbergHartford$23K
- Sarp AkselStamford$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.